AAAAAA
Results:
1-23
|
Results: 23
Authors:
Levy, GA
Citation: Ga. Levy, Long-term immunosuppression and drug interactions, LIVER TRANS, 7(11), 2001, pp. S53-S59
Authors:
Clark, DA
Ding, JW
Yu, G
Levy, GA
Gorczynski, RM
Citation: Da. Clark et al., Fg12 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2, MOL HUM REP, 7(2), 2001, pp. 185-194
Authors:
Levy, GA
Citation: Ga. Levy, C-2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral((R) 1) formulation, BIODRUGS, 15(5), 2001, pp. 279-290
Authors:
Knackstedt, M
Ding, JW
Arck, PC
Hertwig, K
Coulam, CB
August, C
Lea, R
Dudenhausen, JW
Gorczynski, RM
Levy, GA
Clark, DA
Citation: M. Knackstedt et al., Activation of the novel prothrombinase, fgl2, as a basis for the pregnancycomplications spontaneous abortion and pre-eclampsia, AM J REPROD, 46(3), 2001, pp. 196-210
Authors:
Clark, DA
Yu, G
Levy, GA
Gorczynski, RM
Citation: Da. Clark et al., Procoagulants in fetus rejection: the role of the OX-2 (CD200) tolerance signal, SEMIN IMMUN, 13(4), 2001, pp. 255-263
Authors:
Yuwaraj, S
Ding, JW
Liu, MF
Marsden, PA
Levy, GA
Citation: S. Yuwaraj et al., Genomic characterization, localization, and functional expression of FGL2 the human gene encoding fibroleukin: A novel human procoagulant, GENOMICS, 71(3), 2001, pp. 330-338
Authors:
Levy, GA
Citation: Ga. Levy, Charity begins at home: A message to the CAG membership, CAN J GASTR, 15(10), 2001, pp. 644-644
Authors:
Malkan, G
Humar, A
Lilly, L
Greig, PD
Grant, D
Wanless, IW
Cameron, R
Levy, GA
Cattrall, MS
Citation: G. Malkan et al., Natural history of recurrent hepatitis C after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1468-1468
Authors:
Levy, GA
Grant, D
Paradis, K
Campestrini, J
Smith, T
Kovarik, JM
Citation: Ga. Levy et al., Pharamacokinetics and tolerability of 40-0-[2-hydroxyethyl]rapamycin in denovo liver transplant recipients, TRANSPLANT, 71(1), 2001, pp. 160-163
Authors:
Cattral, MS
Lilly, LB
Levy, GA
Citation: Ms. Cattral et al., Immunosuppression in liver transplantation, SEM LIV DIS, 20(4), 2000, pp. 523-531
Authors:
Bigam, DL
Pennington, JJ
Carpentier, A
Wanless, IR
Hemming, AW
Croxford, R
Greig, PD
Lilly, LB
Heathcote, JE
Levy, GA
Cattral, MS
Citation: Dl. Bigam et al., Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation, HEPATOLOGY, 32(1), 2000, pp. 87-90
Authors:
Levy, GA
Citation: Ga. Levy, Neoral use in the liver transplant recipient, TRANSPLAN P, 32(3A), 2000, pp. 2S-9S
Authors:
Belitsky, P
Levy, GA
Johnston, A
Citation: P. Belitsky et al., Neoral absorption profiling: An evolution in effectiveness, TRANSPLAN P, 32(3A), 2000, pp. 45S-52S
Authors:
Malkan, G
Cattral, MS
Humar, A
Al Asghar, H
Greig, PD
Hemming, AW
Levy, GA
Lilly, LB
Citation: G. Malkan et al., Lamivudine for hepatitis B in liver transplantation - A single-center experience, TRANSPLANT, 69(7), 2000, pp. 1403-1407
Authors:
Levy, GA
Liu, MF
Ding, JW
Yuwaraj, S
Leibowitz, J
Marsden, PA
Ning, Q
Kovalinka, A
Phillips, MJ
Citation: Ga. Levy et al., Molecular and functional analysis of the human prothrombinase gene (HFGL2)and its role in viral hepatitis, AM J PATH, 156(4), 2000, pp. 1217-1225
Authors:
Levy, GA
Citation: Ga. Levy, Neoral/cyclosporine-based immunosuppression, LIVER TR S, 5(4), 1999, pp. S37-S47
Authors:
Clark, DA
Ding, JW
Chaouat, G
Coulam, CB
August, C
Levy, GA
Citation: Da. Clark et al., The emerging role of immunoregulation of fibrinogen-related procoagulant fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans, AM J REPROD, 42(1), 1999, pp. 37-43
Authors:
Perampalam, S
Wang, LQ
Myers-Mason, N
Yeow, JN
Stanietsky, N
Phillips, J
Weitz, JI
Ackerley, C
Levy, GA
Cole, EH
Citation: S. Perampalam et al., Identification of a unique glomerular factor X activator in murine lupus nephritis, J AM S NEPH, 10(11), 1999, pp. 2332-2341
Authors:
Sim, KH
Marinov, A
Levy, GA
Citation: Kh. Sim et al., Xenotransplantation: A potential solution to the critical organ donor shortage, CAN J GASTR, 13(4), 1999, pp. 311-318
Authors:
Levy, GA
Citation: Ga. Levy, Relationship of pharmacokinetics to clinical outcomes, TRANSPLAN P, 31(3), 1999, pp. 1654-1658
Authors:
Hemming, AW
Cattral, MS
Greig, PD
Lilly, LB
Ashby, P
Levy, GA
Citation: Aw. Hemming et al., Domino liver transplantation for familial amyloid polyneuropathy: Optimal use of a scarce resource, TRANSPLAN P, 31(1-2), 1999, pp. 515-515
Authors:
Cattral, MS
Hemming, AW
Wanless, IR
Al Ashgar, H
Krajden, M
Lilly, L
Greig, PD
Levy, GA
Citation: Ms. Cattral et al., Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation, TRANSPLANT, 67(9), 1999, pp. 1277-1280
Authors:
Clark, DA
Chaouat, G
Arck, PC
Mittruecker, HW
Levy, GA
Citation: Da. Clark et al., Cutting edge: Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase (vol 160, pg 545, 1998), J IMMUNOL, 162(5), 1999, pp. 3105-3105
Risultati:
1-23
|